Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IA Enbrel in Refractory Knee Joint Synovitis
NCT00678782Phase 2Completed
- Sponsor
- Università di Padova
- Start
- Apr 2005
- Primary completion
- Dec 2007
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of etanercept in knee synovitis, sponsored by Università di Padova. Started Apr 2005; status: completed.
02
Drugs
etanercept
03
Conditions
knee synovitis
Beyond the preview
Go deeper on NCT00678782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00678782.